43 studies found for:    0815
Show Display Options
Rank Status Study
1 Completed Relapse Prevention With Varenicline
Conditions: Recurrence;   Smoking Cessation;   Substance-Related Disorders
Interventions: Drug: Varenicline;   Drug: Placebo
2 Completed
Has Results
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Drug: Sorafenib;   Drug: Erlotinb
3 Completed Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Conditions: Childhood Central Nervous System Choriocarcinoma;   Childhood Central Nervous System Embryonal Tumor;   Childhood Central Nervous System Germ Cell Tumor;   Childhood Central Nervous System Germinoma;   Childhood Central Nervous System Mixed Germ Cell Tumor;   Childhood Central Nervous System Teratoma;   Childhood Central Nervous System Yolk Sac Tumor;   Metastatic Childhood Soft Tissue Sarcoma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Central Nervous System Embryonal Tumor;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Visual Pathway Glioma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: pazopanib hydrochloride;   Other: pharmacological study
4 Recruiting Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
Conditions: Stable Coronary Artery Disease;   Obesity;   Impaired Glucose Tolerance
Interventions: Other: training;   Other: training + metformin;   Other: training + glitazon
5 Recruiting Enhancement of Hand Motor Function After Cervical Spinal Cord Injury
Condition: Spinal Cord Injury
Interventions: Procedure: High frequency non-invasive repetitive transcranial magnetic stimulation;   Procedure: Sham rTMS over control brain area
6 Recruiting Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
7 Terminated Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Condition: Melanoma
Intervention:
8 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
9 Completed Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BDP/formoterol NEXT DPI
10 Completed A Key Link for Transmission Prevention
Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages;   Behavioral: 5 counselor-delivered sessions;   Drug: ARVs with raltegravir and emtricitabine/tenofovir disoproxil fumarate
11 Completed Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
12 Completed Hypopituitarism After Aneurismal Subarachnoid Hemorrhage
Conditions: Aneurismal Subarachnoid Hemorrhage;   Hypopituitarism;   Neuropsychological Deficits
Intervention:
13 Completed
Has Results
Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: gemcitabine;   Drug: cisplatin
14 Unknown  Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
Condition: Colorectal Cancer
Interventions: Drug: tegafur-uracil;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis
15 Active, not recruiting A Study Comparing LY2605541 With Insulin Glargine as Basal Insulin Treatment
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LY2605541;   Drug: Insulin Glargine
16 Completed Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: docetaxel + S-1;   Drug: S-1
17 Active, not recruiting Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Condition: Diabetic Nephropathies
Interventions: Drug: BAY94-8862;   Drug: Placebo;   Drug: BAY 94-8862
18 Completed Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment
Condition: Postmenopausal Women With Advanced Breast Cancer
Intervention: Drug: Letrozole
19 Completed A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: continuous infusion of 5-fluorouracil;   Drug: combination of irinotecan and cisplatin;   Drug: oral administration of S-1
20 Unknown  A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC
Condition: Small-Cell-Lung Cancer
Interventions: Drug: Etoposide and cisplatin after chemoradiotherapy;   Drug: Irinotecan and cisplatin after chemoradiotherapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years